Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AXSM Axsome Therapeutics, Inc.

休市中 05-02 16:00:00 EDT

112.21

-0.03

-0.03%

盘后112.21

+0.000.00%

19:35 EDT

最高114.01	最低111.13	成交量70.08万
今开113.10	昨收112.24	日振幅2.57%
总市值55.23亿	流通市值41.54亿	总股本4,922万
成交额7,867万	换手率1.89%	流通股本3,702万
市净率96.87	ROE-231.63%	每股收益-5.99
52周最高139.13	52周最低64.11	市盈率-18.72
股息0.00	股息收益率0.00	ROA-27.28%

北京优虎网络科技有限公司

{"stockData":{"symbol":"AXSM","market":"US","secType":"STK","nameCN":"Axsome Therapeutics, Inc.","latestPrice":112.21,"timestamp":1746216000000,"preClose":112.24,"halted":0,"volume":700760,"hourTrading":{"tag":"盘后","latestPrice":112.21,"preClose":112.21,"latestTime":"19:35 EDT","volume":6565,"amount":736844.4488,"timestamp":1746228929375},"delay":0,"floatShares":37015550,"shares":49219312,"eps":-5.994374,"marketStatus":"休市中","change":-0.03,"latestTime":"05-02 16:00:00 EDT","open":113.1,"high":114.01,"low":111.13,"amount":78666998.05344,"amplitude":0.025659,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.994374,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1447909200000,"exchange":"NASDAQ","adjPreClose":112.24,"preHourTrading":{"tag":"盘前","latestPrice":113.02,"preClose":112.24,"latestTime":"09:29 EDT","volume":343,"amount":38691.24035,"timestamp":1746192599999},"postHourTrading":{"tag":"盘后","latestPrice":112.21,"preClose":112.21,"latestTime":"19:35 EDT","volume":6565,"amount":736844.4488,"timestamp":1746228929375},"volumeRatio":1.2645906322290725,"impliedVol":0.4707,"impliedVolPercentile":0.412},"requestUrl":"/m/hq/s/AXSM/wiki","defaultTab":"wiki","newsList":[{"id":"2527194044","title":"Axsome Therapeutics, Inc.涨1.55% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2527194044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527194044?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:33","pubTimestamp":1744637591,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时33分，Axsome Therapeutics, Inc.股票出现异动，股价快速拉升1.55%。截至发稿，该股报99.58美元/股，成交量1.2179万股，换手率0.02%，振幅0.93%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Theratechnologies Inc.涨幅较大，Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为276.95%、134.20%、86.81%，振幅较大的相关个股有Verrica制药、Neuraxis, Inc.、Artelo Biosciences, Inc.，振幅分别为17.60%、15.64%、13.38%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213311a6ba1c8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213311a6ba1c8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AXSM","BK4585","BK4007","BK4139","LENZ","BK4505"],"gpt_icon":0},{"id":"2518277592","title":"Axsome Therapeutics, Inc.盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518277592?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:42","pubTimestamp":1741617767,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时42分，Axsome Therapeutics, Inc.股票出现异动，股价大幅跳水5.00%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3487.28%、761.92%、648.51%，振幅较大的相关个股有Scisparc Ltd.、Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为45.06%、41.36%、40.33%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310224248abf31732&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310224248abf31732&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4505","AXSM","BK4585","LENZ"],"gpt_icon":0},{"id":"2516579633","title":"Baird：维持Axsome Therapeutics(AXSM.US)评级，由优于大市调整至优于大市评级, 目标价由132.00美元调整至160.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516579633","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516579633?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:51","pubTimestamp":1741006288,"startTime":"0","endTime":"0","summary":"Baird：维持Axsome Therapeutics(AXSM.US)评级，由优于大市调整至优于大市评级, 目标价由132.00美元调整至160.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03205148492765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","AXSM"],"gpt_icon":0},{"id":"2514857535","title":"瑞穗银行：维持Axsome Therapeutics(AXSM.US)评级，由优于大市调整至优于大市评级, 目标价由195.00美元调整至212.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514857535","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514857535?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:11","pubTimestamp":1740586273,"startTime":"0","endTime":"0","summary":"瑞穗银行：维持Axsome Therapeutics(AXSM.US)评级，由优于大市调整至优于大市评级, 目标价由195.00美元调整至212.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27001148413683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","AXSM","161121"],"gpt_icon":0},{"id":"1132091385","title":"异动解读 | Axsome Therapeutics盘中大跌5.03% 分析师称业绩及估值或为主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1132091385","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132091385?lang=zh_cn&edition=full","pubTime":"2025-02-26 03:04","pubTimestamp":1740510275,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics, Inc.(AXSM)今日盘中大跌5.03%,引发了市场广泛关注。\n\nAXSM是一家致力于开发治疗中枢神经系统疾病的新疗法的生物制药公司。从最新财报数据看,公司营收3.86亿美元,净利润则达-2.87亿美元,每股亏损5.99美元。较高的亏损可能是导致股价下跌的主要原因之一。\n\n同时,分析师普遍认为,该公司股价目前市盈率过高,约为-20.76倍,短期内增长动能不足,估值面临压力。机构方面给予100%买入评级,但显然并没能阻止股价下跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Axsome Therapeutics盘中大跌5.03% 分析师称业绩及估值或为主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AXSM"],"gpt_icon":0},{"id":"2514139048","title":"Axsome Therapeutics, Inc.盘中异动 下午盘快速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514139048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514139048?lang=zh_cn&edition=full","pubTime":"2025-02-26 03:01","pubTimestamp":1740510114,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日03时01分，Axsome Therapeutics, Inc.股票出现异动，股价快速下跌5.04%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1940.33%、1162.55%、995.72%，振幅较大的相关个股有Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp，振幅分别为241.19%、112.90%、87.83%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260301549892802b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260301549892802b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","AXSM","BK4007","BK4585","LENZ","BK4139"],"gpt_icon":0},{"id":"2513778342","title":"Axsome Therapeutics, Inc.盘中异动 早盘股价大跌5.15%报130.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513778342?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:04","pubTimestamp":1740409483,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时04分，Axsome Therapeutics, Inc.股票出现异动，股价大幅下跌5.15%。截至发稿，该股报130.65美元/股，成交量22.0085万股，换手率0.45%，振幅4.89%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为160.26%、70.68%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230443abdb160d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230443abdb160d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4585","AXSM","BK4007","BK4139"],"gpt_icon":0},{"id":"2513902542","title":"Axsome Therapeutics, Inc.盘中异动 快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513902542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513902542?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:28","pubTimestamp":1740155326,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时28分，Axsome Therapeutics, Inc.股票出现异动，股价大幅拉升5.02%。截至发稿，该股报135.58美元/股，成交量43.6884万股，换手率0.90%，振幅5.52%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Nkgen Biotech, Inc.、Invivyd, Inc.、Osr Holdings, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为201.91%、142.45%、119.77%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.，振幅分别为70.43%、57.50%、48.19%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222002847abd7c910&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222002847abd7c910&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AXSM","BK4505","BK4007","LENZ","BK4585","BK4139"],"gpt_icon":0},{"id":"2513689292","title":"Axsome Therapeutics, Inc.2024财年实现净利润-2.87亿美元，同比减少20.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513689292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513689292?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:00","pubTimestamp":1740153636,"startTime":"0","endTime":"0","summary":"2月22日，Axsome Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-2.87亿美元，同比减少20.08%；其中营业收入为3.86亿美元，同比增加42.44%，每股基本收益为-5.99美元。机构评级：截至2025年2月22日，当前有17家机构对Axsome Therapeutics, Inc.目标价做出预测，其中目标均价为166.47美元，其中最低目标价为121.00美元，最高目标价为200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000053a24ec476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000053a24ec476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AXSM","LENZ"],"gpt_icon":0},{"id":"2512748730","title":"Truist Securities：维持Axsome Therapeutics(AXSM.US)评级，由买入调整至买入评级, 目标价由190.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512748730","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512748730?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:11","pubTimestamp":1739985063,"startTime":"0","endTime":"0","summary":"Truist Securities：维持Axsome Therapeutics(AXSM.US)评级，由买入调整至买入评级, 目标价由190.00美元调整至200.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/20011148268171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AXSM","LENZ"],"gpt_icon":0},{"id":"1160394100","title":"异动解读 | 财报未达预期 Axsome Therapeutics盘中大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160394100","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160394100?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:34","pubTimestamp":1739889272,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics公司股价今日盘中大跌5.41%,引发了市场的广泛关注。这与公司2024年第四季度财报表现未达预期密切相关。\n\n公司此前公布的季度财报显示,每股亏损为1.54美元,远低于分析师普遍预期的1.03美元亏损。尽管相比去年同期每股亏损2.08美元有所改善,但错失市场预期成为打击。另一方面,公司季度销售额达到11.877亿美元,虽然小幅超出11.764亿美元的预期,但同比增长66.03%的增速未能令投资者满意。\n\n财报表现令公司基本面遭到质疑,资金持续流出,引发股价大幅下挫。未来公司能否通过扩大销售规模和控制成本来扭转亏损局面,将决定其盈利能力和股价表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AXSM"],"gpt_icon":0},{"id":"1194208347","title":"Axsome Therapeutics 2024年第四季度GAAP每股收益$(1.54) 未达$(1.03)预期，销售额$1.1877亿超出$1.1764亿预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1194208347","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194208347?lang=zh_cn&edition=full","pubTime":"2025-02-18 20:06","pubTimestamp":1739880387,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics 报告季度每股亏损$，未达到分析师普遍预期的$，差距为49.51%。公司报告季度销售额为$1.1877亿，超出分析师普遍预期的$1.1764亿，超出幅度为0.95%。相比去年同期的$7153万，销售额增长了66.03%。以上内容来自Benzinga Earnings专栏，原文如下：Axsome $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 49.51 percent. This is a 25.96 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $118.77 million which beat the analyst consensus estimate of $117.64 million","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Axsome Therapeutics 2024年第四季度GAAP每股收益$(1.54) 未达$(1.03)预期，销售额$1.1877亿超出$1.1764亿预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM"],"gpt_icon":0},{"id":"2510141358","title":"Axsome Therapeutics(AXSM.US)获德银首次覆盖，给予买入评级, 目标价176.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510141358","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510141358?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:02","pubTimestamp":1739296955,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics(AXSM.US)获德银首次覆盖，给予买入评级, 目标价176.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12020248092618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AXSM","LENZ"],"gpt_icon":0},{"id":"2510934338","title":"Axsome Therapeutics, Inc.盘中异动 股价大涨5.23%报133.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510934338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510934338?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:53","pubTimestamp":1739285593,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时53分，Axsome Therapeutics, Inc.股票出现波动，股价快速拉升5.23%。截至发稿，该股报133.73美元/股，成交量30.0207万股，换手率0.62%，振幅3.92%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.29%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2391.30%、659.43%、292.40%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为45.29%、33.04%、33.02%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112253149881c155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112253149881c155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4585","AXSM","BK4505","BK4007"],"gpt_icon":0},{"id":"2510813004","title":"Leerink Partners：维持Axsome Therapeutics(AXSM.US)评级，由优于大市调整至优于大市评级, 目标价由110.00美元调整至150.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510813004","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510813004?lang=zh_cn&edition=full","pubTime":"2025-02-11 05:52","pubTimestamp":1739224325,"startTime":"0","endTime":"0","summary":"Leerink Partners：维持Axsome Therapeutics(AXSM.US)评级，由优于大市调整至优于大市评级, 目标价由110.00美元调整至150.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/11055248064839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","AXSM"],"gpt_icon":0},{"id":"2510863484","title":"Axsome Therapeutics, Inc.盘中异动 股价大涨14.02%报120.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510863484?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197908,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Axsome Therapeutics, Inc.股票出现异动，股价大幅上涨14.02%。截至发稿，该股报120.59美元/股，成交量24.0542万股，换手率0.50%，振幅3.07%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为1468.04%、836.01%、551.28%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Aditxt, Inc.、Tc Biopharm  Plc，振幅分别为8.85%、6.44%、5.96%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223148abc9a4f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223148abc9a4f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4139","AXSM","LENZ","BK4007"],"gpt_icon":0},{"id":"2509496943","title":"Axsome Therapeutics, Inc.盘中异动 下午盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509496943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509496943?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:09","pubTimestamp":1738699760,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时09分，Axsome Therapeutics, Inc.股票出现波动，股价快速上涨5.03%。截至发稿，该股报112.84美元/股，成交量48.9723万股，换手率1.01%，振幅4.40%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.56%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028、Mink Therapeutics, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1942.00%、987.78%、586.57%，振幅较大的相关个股有Azitra Inc、Omega Therapeutics, Inc.、Mink Therapeutics, Inc.，振幅分别为123.99%、59.42%、58.27%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020504092096180c0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020504092096180c0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","AXSM","BK4007","BK4585","LENZ","BK4139"],"gpt_icon":0},{"id":"2508126036","title":"Truist Securities：维持Axsome Therapeutics(AXSM.US)评级，由买入调整至买入评级, 目标价由180.00美元调整至190.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508126036","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508126036?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:54","pubTimestamp":1738605252,"startTime":"0","endTime":"0","summary":"Truist Securities：维持Axsome Therapeutics(AXSM.US)评级，由买入调整至买入评级, 目标价由180.00美元调整至190.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/04015447942415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","AXSM"],"gpt_icon":0},{"id":"2508406147","title":"加拿大皇家银行：维持Axsome Therapeutics(AXSM.US)评级，由优于大市调整至优于大市评级, 目标价由139.00美元调整至143.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508406147","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508406147?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:58","pubTimestamp":1738598321,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：维持Axsome Therapeutics(AXSM.US)评级，由优于大市调整至优于大市评级, 目标价由139.00美元调整至143.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/03235847942174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","AXSM"],"gpt_icon":0},{"id":"2507608142","title":"Axsome Therapeutics, Inc.盘中异动 急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507608142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507608142?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:45","pubTimestamp":1738269959,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时45分，Axsome Therapeutics, Inc.股票出现异动，股价快速上涨5.10%。截至发稿，该股报110.50美元/股，成交量72.2355万股，换手率1.49%，振幅5.52%。Axsome Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Dominari Holdings Inc.涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1836.40%、340.14%、257.60%，振幅较大的相关个股有Dominari Holdings Inc.、Cero Therapeutics Holdings, Inc.、Kazia Therapeutics Limited，振幅分别为70.55%、65.98%、65.94%。Axsome Therapeutics, Inc.公司简介：Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013104455996146658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013104455996146658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4007","BK4505","BK4139","LENZ","AXSM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.axsome.com","stockEarnings":[{"period":"1week","weight":0.0559},{"period":"1month","weight":0.0224},{"period":"3month","weight":0.054},{"period":"6month","weight":0.2631},{"period":"1year","weight":0.5125},{"period":"ytd","weight":0.3262}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Axsome Therapeutics, Inc.成立于2012年1月。该公司是一家临床阶段的生物制药企业，开发新的治疗疼痛和其他中枢神经系统或中枢神经系统，疾病管理。通过专注于这一治疗领域，他们正在解决显著和不断增长的市场，其中目前的治疗选择是有限或不充分的。他们的目标是成为一个完全集成的生物制药公司开发和商业化的拓展提供给医护人员的治疗方案，提高生活疼痛和其他中枢神经系统疾病患者的生命分化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.080962},{"month":2,"riseRate":0.2,"avgChangeRate":-0.029639},{"month":3,"riseRate":0.3,"avgChangeRate":0.057923},{"month":4,"riseRate":0.7,"avgChangeRate":0.151343},{"month":5,"riseRate":0.3,"avgChangeRate":-0.046725},{"month":6,"riseRate":0.666667,"avgChangeRate":0.138679},{"month":7,"riseRate":0.555556,"avgChangeRate":-0.030202},{"month":8,"riseRate":0.555556,"avgChangeRate":0.036801},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.021887},{"month":10,"riseRate":0.444444,"avgChangeRate":0.001108},{"month":11,"riseRate":0.666667,"avgChangeRate":0.158013},{"month":12,"riseRate":0.7,"avgChangeRate":0.188795}],"exchange":"NASDAQ","name":"Axsome Therapeutics, Inc.","nameEN":"Axsome Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Axsome Therapeutics, Inc.(AXSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Axsome Therapeutics, Inc.,AXSM,Axsome Therapeutics, Inc.股票,Axsome Therapeutics, Inc.股票老虎,Axsome Therapeutics, Inc.股票老虎国际,Axsome Therapeutics, Inc.行情,Axsome Therapeutics, Inc.股票行情,Axsome Therapeutics, Inc.股价,Axsome Therapeutics, Inc.股市,Axsome Therapeutics, Inc.股票价格,Axsome Therapeutics, Inc.股票交易,Axsome Therapeutics, Inc.股票购买,Axsome Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Axsome Therapeutics, Inc.(AXSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}